State of the art: the evolving role of RT in combined modality therapy for GBM
J Neurooncol
.
2017 Sep;134(3):477-478.
doi: 10.1007/s11060-017-2596-4.
Authors
Ranjit S Bindra
1
,
Eva Galanis
2
,
Minesh P Mehta
3
Affiliations
1
Department of Therapeutic Radiology, Yale University, School of Medicine, New Haven, CT, 06510, USA. ranjit.bindra@yale.edu.
2
Mayo Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA. galanis.evanthia@mayo.edu.
3
Miami Cancer Institute, 1575 San Ignacio Avenue, Suite 100, Coral Gables, Miami, FL, 33146, USA. mineshpmehta@gmail.com.
PMID:
28913783
PMCID:
PMC5866384
DOI:
10.1007/s11060-017-2596-4
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Brain Neoplasms / radiotherapy*
Combined Modality Therapy / trends
Glioblastoma / radiotherapy*
Humans
Grants and funding
R03 CA194967/CA/NCI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States